Inmar offers technology-driven, industry-leading solutions to improve profitability and increase patient engagement.

JOIN US FOR AN UPCOMING HEALTHCARE EVENT

With rising costs, regulations and competitive pressure, it’s more challenging than ever to grow revenue. As the leader in Rx returns — serving pharma manufacturers, hospitals, long-term care and retailers — Inmar Intelligence collects 30+ million pounds of Rx products annually. We offer comprehensive solutions to help drive efficiency and improve processes, empowering brands to inform, interact with and inspire patients. The results? Revenue growth, increased profitability and strengthened brand equity.

Inmar's comprehensive pharmaceutical returns management solution for manufacturers drives increased efficiency.

Manufacturer Pharmaceutical Returns

Our comprehensive pharmaceutical returns management solution for manufacturers drives increased efficiency through state-of-the-art technologies including:

  • One Touch Advantage® processing
  • Online returns management
  • A Returns Authorization (RA) tool

Our solution ensures your processes for returns and disposition are compliant, and delivers:

  • Industry-leading accuracy
  • Automation
  • Policy Management
  • Reconciliation
  • Documentation
  • Benchmarking

Learn More

Inmar helps protect Rx manufacturer brands through our professional recall consulting, planning and regulatory services and end-to-end recall execution.

OneRecall® for Pharmaceutical Manufacturers

We help protect manufacturer brands through our professional recall consulting, planning and regulatory services and end-to-end recall execution. We guide companies through all the steps of a recall event — helping minimize impact through comprehensive process optimization, notification/response, product retrieval, compliant disposition, and performance analytics for regulatory reporting and process improvement.

Learn More

National Consumer Drug Take-Back Collection Receptacle Icon

Sponsored Consumer Drug Take-Back

As the diversion, abuse and improper disposal of prescription drugs continue to threaten public health, state governments across the country are requiring pharmaceutical manufacturers to help execute, and pay for, consumer drug take-back programs. We leverage our resources and systems in place, as well as our relationships with more than 50,000 pharmacies and health systems throughout the United States, to ensure that subscribing manufacturers are able to fully comply with each state’s program requirements — and do so with cost certainty and containment.

Learn More